← Back to guidelines
Infectious Disease131 papers

Myocardial dysfunction with sepsis

Last edited: 4/10/2026

Overview

Sepsis is a life-threatening condition characterized by acute, life-threatening multiple organ dysfunction triggered by an infection 1. Myocardial dysfunction is a recognized complication of sepsis, contributing to overall organ failure 1.

Diagnosis

  • Mid-regional pro-adrenomedullin (MR-proADM) demonstrates high sensitivity (0.83) and specificity (0.90) for sepsis diagnosis, with an optimal cut-off value of 1-1.5 nmol/L 5.
  • MR-proADM may also aid in distinguishing pathogens, identifying sepsis severity, and assessing organ failure 5.
  • Point-of-care ultrasound (POCUS) can be used for shock assessment 2.
  • Management

  • Early enteral nutrition (EEN) within 48 hours may be safe and effective for critically ill patients with sepsis or septic shock 4.
  • Therapeutic plasma exchange (TPE) as an adjunct to standard therapy significantly reduced short-term mortality in critically ill adult septic patients 3.
  • Guidelines address diagnosis and treatment of infection and organ failure in sepsis 1.
  • Special Populations

  • No specific information regarding myocardial dysfunction in pregnancy, pediatrics, elderly, or patients with comorbidities during sepsis was found in the provided abstracts.
  • Key Recommendations

  • Therapeutic plasma exchange (TPE) as an adjunct to standard care significantly reduced short-term mortality in critically ill adult septic patients 3. (Evidence: Strong)
  • Early enteral nutrition (EEN) within 48 hours may be a safe and effective intervention for critically ill patients with sepsis or septic shock 4. (Evidence: Weak)
  • Mid-regional pro-adrenomedullin (MR-proADM) is an excellent biomarker for sepsis diagnosis with high sensitivity and specificity, with an optimal cut-off of 1-1.5 nmol/L 5. (Evidence: Strong)
  • References

    1 Brunkhorst FM, Adamzik M, Axer H, Bauer M, Bode C, Bone HG et al.. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025]. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2025. link 2 Liu Q, Ma X, Li S, Li Z, Mo Z, Lin Y et al.. Effectiveness of a multi-model teaching strategy to train emergency medicine residents to use point-of-care ultrasound (POCUS) for assessment of shock. BMC medical education 2025. link 3 Kuklin V, Sovershaev M, Bjerner J, Keith P, Scott LK, Thomas OMT et al.. Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis. Critical care (London, England) 2024. link 4 Grillo-Ardila CF, Tibavizco-Palacios D, Triana LC, Rugeles SJ, Vallejo-Ortega MT, Calderón-Franco CH et al.. Early Enteral Nutrition (within 48 h) for Patients with Sepsis or Septic Shock: A Systematic Review and Meta-Analysis. Nutrients 2024. link 5 Li P, Wang C, Pang S. The diagnostic accuracy of mid-regional pro-adrenomedullin for sepsis: a systematic review and meta-analysis. Minerva anestesiologica 2021. link 6 Ge L, Zhao J, Deng H, Chen C, Hu Z, Zeng L. Effect of Bone Marrow Mesenchymal Stromal Cell Therapies in Rodent Models of Sepsis: A Meta-Analysis. Frontiers in immunology 2021. link

    Original source

    1. [1]
      [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Brunkhorst FM, Adamzik M, Axer H, Bauer M, Bode C, Bone HG et al. Medizinische Klinik, Intensivmedizin und Notfallmedizin (2025)
    2. [2]
    3. [3]
    4. [4]
      Early Enteral Nutrition (within 48 h) for Patients with Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.Grillo-Ardila CF, Tibavizco-Palacios D, Triana LC, Rugeles SJ, Vallejo-Ortega MT, Calderón-Franco CH et al. Nutrients (2024)
    5. [5]
    6. [6]
      Effect of Bone Marrow Mesenchymal Stromal Cell Therapies in Rodent Models of Sepsis: A Meta-Analysis.Ge L, Zhao J, Deng H, Chen C, Hu Z, Zeng L Frontiers in immunology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG